IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth.
about
Identification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancerUnraveling insulin-like growth factor binding protein-3 actions in human diseaseAn ocular view of the IGF-IGFBP systemThe role and interaction of imprinted genes in human fetal growthAstrocyte-derived vascular endothelial growth factor stabilizes vessels in the developing retinal vasculatureThe mouse retina as an angiogenesis model.Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesisGhrelin modulates physiologic and pathologic retinal angiogenesis through GHSR-1aInsulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation.Regulation of retinal endothelial cell apoptosis through activation of the IGFBP-3 receptor.Longitudinal infusion of a complex of insulin-like growth factor-I and IGF-binding protein-3 in five preterm infants: pharmacokinetics and short-term safetyTargeting insulin-like growth factor-I and insulin-like growth factor-binding protein-3 signaling pathways. A novel therapeutic approach for asthmaStudies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis)Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) miceEffects of long-term averaging of quantitative blood pressure traits on the detection of genetic associationsFree insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase).Understanding retinopathy of prematurity: update on pathogenesis.Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life.PLD1-dependent PKCgamma activation downstream to Src is essential for the development of pathologic retinal neovascularization.Postnatal weight gain modifies severity and functional outcome of oxygen-induced proliferative retinopathy.Context- and cell-dependent effects of Delta-like 4 targeting in the bone marrow microenvironment.Novel protective properties of IGFBP-3 result in enhanced pericyte ensheathment, reduced microglial activation, increased microglial apoptosis, and neuronal protection after ischemic retinal injury.Prolyl hydroxylase domain protein 2 (PHD2) mediates oxygen-induced retinopathy in neonatal micePioglitazone restores IGFBP-3 levels through DNA PK in retinal endothelial cells cultured in hyperglycemic conditions.Insulin-like growth factor-binding protein-3 (IGFBP-3) blocks the effects of asthma by negatively regulating NF-κB signaling through IGFBP-3R-mediated activation of caspases.Transcriptome sequencing reveals differences between primary and secondary hair follicle-derived dermal papilla cells of the Cashmere goat (Capra hircus).IGFBP-3 inhibits TNF-α production and TNFR-2 signaling to protect against retinal endothelial cell apoptosis.Insulin-like growth factor binding protein-3 is required for the regulation of rat oval cell proliferation and differentiation in the 2AAF/PHX model.Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse modelThe genetic control of avascular area in mouse oxygen-induced retinopathyA pharmacokinetic and dosing study of intravenous insulin-like growth factor-I and IGF-binding protein-3 complex to preterm infantsAberrant kinetics of bone marrow-derived endothelial progenitor cells in the murine oxygen-induced retinopathy model.Elevated IGFBP3 levels in diabetic tears: a negative regulator of IGF-1 signaling in the corneal epithelium.IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development.Hypoxia induces IGFBP3 in esophageal squamous cancer cells through HIF-1α-mediated mRNA transcription and continuous protein synthesisCompound 49b prevents diabetes-induced apoptosis through increased IGFBP-3 levelsMEF2C ablation in endothelial cells reduces retinal vessel loss and suppresses pathologic retinal neovascularization in oxygen-induced retinopathycGMP-Phosphodiesterase Inhibition Prevents Hypoxia-Induced Cell Death Activation in Porcine Retinal ExplantsTMP prevents retinal neovascularization and imparts neuroprotection in an oxygen-induced retinopathy model.Can a Risk Factor Based Approach Safely Reduce Screening for Retinopathy of Prematurity?
P2860
Q24604176-AD126172-8681-434E-8FE1-2F712E293F35Q24650060-F44BB89F-C77F-4C91-9627-EEE3A712C30AQ27013698-A10C6B22-F7FF-489F-AC60-FA63686656B4Q28083223-1DE989F7-3F9F-489C-B407-D7C8D9889B65Q28750081-65B71287-D5F0-4B6B-8942-FB13EB6C0877Q30495106-7DC87C4C-FFCF-4C4F-B089-ECBA5A76194BQ30542079-6C180E0D-0510-4F6B-907A-8CF24A09FA5BQ30968571-F9B51112-901E-4B08-9EC8-408E33576B12Q33504506-2A02324C-42B6-4BD0-A32E-6BAC65541662Q33632210-E529D45E-BFCE-4383-A828-9D3B38FBB165Q33640027-615234D0-BE88-41F1-9B84-F684C5A97077Q33756365-1A5624EC-E593-4ECE-A8A4-C6BD25AC1ED8Q33787955-2F8BC6CA-7478-4786-89EA-D851AAFEC106Q33808187-564B28AD-C3AE-45E7-BA42-498D877DDD2BQ33858783-0075055E-FB95-4D7D-837D-507A8F93A246Q34022792-403E7C4F-A9D1-4B7C-A6A1-5365056F41ABQ34038976-CFDDA88C-15CD-4E39-838F-5CF4B6E8F2F4Q34090125-06529209-194E-4DB7-9DCD-15A4187E9C0EQ34122706-985C6C33-2895-4EE4-81AF-6A519C7ADEC7Q34358139-BC38BE14-C9E9-49C0-ACF6-6EC31EB113B9Q34533929-0D872257-B35C-4353-A7E1-2F2385EDC41FQ34805398-C25903C4-BA3A-400F-A6CC-8925A7F9B9C0Q34805681-21CBB739-0C73-4D36-9DF8-C6AD5BC3419BQ34956067-0F3D78D3-0336-43E4-85E9-2BBB8774C035Q34979016-26B083B2-DCFD-4D58-A784-6F830579E906Q34999770-8E62FB87-75BC-448B-8E5D-C4F61A3BF197Q35136744-C5B93E71-8551-4AC2-BF64-A1D0378B0F0BQ35165646-D4E77CD1-EB70-43A9-9465-C794F87DC5EAQ35221114-14F1C3A8-7D5E-4512-835D-C8D486363F41Q35768528-3BE6B01F-1404-404D-853D-F9463C1F77F2Q35800245-4925C181-3A27-48FA-83A4-F51C5118816AQ35826633-4B8E411D-A369-486E-B097-63121F3570F9Q35878260-6EBEED48-3BA3-4ED8-99D3-D022D1055E2AQ35973411-2D370A28-3232-4189-89C6-90CDDD626FDFQ35987892-DF653A03-F8CE-40DB-A50D-540F684A0DADQ36041947-73F1DBBA-03E5-43A3-A079-F11241549718Q36044670-38896BD8-BA00-4DB6-BE84-2C59D1D5A84BQ36197680-7C4A45E4-BE69-4C82-9C73-0CE83B775C58Q36232684-D642A070-8F85-47CC-851D-E05E491517E5Q36271090-85E2617D-826A-48B2-BDB2-1210E5FBBF8D
P2860
IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
IGFBP3 suppresses retinopathy ...... romotion of vascular regrowth.
@ast
IGFBP3 suppresses retinopathy ...... romotion of vascular regrowth.
@en
type
label
IGFBP3 suppresses retinopathy ...... romotion of vascular regrowth.
@ast
IGFBP3 suppresses retinopathy ...... romotion of vascular regrowth.
@en
prefLabel
IGFBP3 suppresses retinopathy ...... romotion of vascular regrowth.
@ast
IGFBP3 suppresses retinopathy ...... romotion of vascular regrowth.
@en
P2093
P2860
P50
P356
P1476
IGFBP3 suppresses retinopathy ...... promotion of vascular regrowth
@en
P2093
Alexandra C H Smith
Christopher M Aderman
John E Pintar
Lois E H Smith
Thomas Ludwig
P2860
P304
10589-10594
P356
10.1073/PNAS.0702031104
P407
P577
2007-06-13T00:00:00Z